Childhood T Acute Lymphoblastic Leukemia

Childhood T Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Essen Biotech
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00049569	Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	completed	N/A	126	National Cancer Institute (NCI)NIH	1	Oct 8, 2013	clinicaltrials
NCT00016302	Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	completed	N/A	100	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials